Durham-based startup targeting diabetes raises $4.6M, looks for another $10.4M June 19, 2020 Continue Reading
Aerami Therapeutics Signs a Global License Agreement with Vectura Group, Adding an Inhaled Therapy for Patients with Pulmonary Arterial Hypertension to Their Pipeline June 8, 2020 Continue Reading
Aerami Therapeutics Appoints Timm Crowder as Chief Operating Officer February 5, 2020 Continue Reading
